Alzheimer’s Clinical Trials News Roundup: Q4
After months of delays, Alzheon gears up to present data from their pivotal Phase 3 drug trial, while Athira Pharma pays out a settlement…
After months of delays, Alzheon gears up to present data from their pivotal Phase 3 drug trial, while Athira Pharma pays out a settlement…
A Trump executive order has banned DEI initiatives across the federal government. Scientists say the move could undermine trial diversity and derail the quest…
When Eisai announced in a press release this week that they’d secured FDA approval for an Alzheimer’s drug dosage change, it seemed like a…
In 2023, U.S. Surgeon General Dr. Vivek Murthy sounded the alarm about the social isolation and loneliness epidemic. A recent poll found that three…
With the 2024 FDA approval of Eli Lilly’s Kisunla for early-stage Alzheimer’s disease, there are now two fairly similar anti-amyloid on the market in…
Two days after President Donald Trump took office, sweeping bans — mostly temporary — went into effect across the U.S. National Institutes of Health…
Would you still participate in an Alzheimer’s clinical trial if you found out that because of your genetics, you were more vulnerable to serious…
Alzheimer’s disease is a lot more than memory loss. Many people with the disease develop psychiatric problems like agitation — which are hard to…
In the 1950s, doctors Carlton Gajdusek and Vincent Zigas trekked over mountains and across rivers to study a mysterious and fatal neurological disease called…
In 2022, more Canadians died by medical euthanasia than from pneumonia, Alzheimer’s, or liver disease. The Quebec government announced in October that people with…
Athira Pharma, makers of experimental Alzheimer’s drug fosgonimeton, paid up $4 million to settle a federal case following allegations that the company manipulated scientific…
In addition to warmer, drier, more extreme weather, climate change is also causing more active wildfire seasons, and that means more exposure to wildfire…
Mild cognitive impairment and dementia can bring insomnia and other sleep issues. Here are the sleep aids that aren’t considered safe — and eight…
Since their discovery in the 1960s, stem cells have captivated our curiosity. Unlike other cells in the body, stem cells are changeable — they…
This month, the U.S. Senate passed the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Reauthorization Act of 2024. Originally signed into law in…